- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Creatinine test reduces contrast-based nephropathy
Many elderly patients scheduled for contrast-enhanced CT scans who have no reported risk factors may still be at risk of contrast-induced nephropathy. While measuring the creatinine levels is standard, it may be better to assess creatinine clearance as well, according to researchers at the VA North Texas Health Care System.
Many elderly patients scheduled for contrast-enhanced CT scans who have no reported risk factors may still be at risk of contrast-induced nephropathy. While measuring the creatinine levels is standard, it may be better to assess creatinine clearance as well, according to researchers at the VA North Texas Health Care System.
Dr. Mithilesh Kumar and colleagues retrospectively reviewed the charts of 561 consecutive patients during a six-month period. Thirteen percent had a creatinine clearance of less than 50 mL/min, and 25% had clearance less than 60 mL/min. Of these patients, nearly 19% and 22%, respectively, reported no risk factors.
"With these data, we can show referring physicians that it is not an insignificant number of patients who could be put at risk," coauthor Dr. Andre Duerinckx said at the RSNA meeting.
Duerinckx is now the director of MR, CT, and vascular imaging at Forsyth Radiological Associates in Winston-Salem, NC.
Copyright © 2005 CMP Media LLC. All rights reserved.
2/1/05, Issue # 2702, page 18.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
